New York University Cancer Institute — New York, New York

New York University Cancer Institute is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

New York University Cancer Institute has participated in 9 clinical trials.

Therapeutic areas: Disease, Hodgkin, Metastatic Melanoma, Peripheral T-cell Lymphoma.

Sponsors: Seagen Inc., Eisai Inc., Spectrum Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Cancer Institute?

New York University Cancer Institute has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Cancer Institute conducted?

New York University Cancer Institute has 9 clinical trials on record. Their work covers Disease, Hodgkin, Metastatic Melanoma, Peripheral T-cell Lymphoma.

Is New York University Cancer Institute accredited by Crixeo Health?

Yes — New York University Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York University Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.